PAFSC Committee Approves Reclassification of Tiquizium Bromide and Diclofenac as Class 2 OTC Drugs

The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) Committee on Safety of Drugs, an advisory body to the health minister, on March 22 discussed and recommended approval for the reclassification of the gastrointestinal antispasmodic agent tiquizium bromide (brand name: Stopan)...read more